Paternal RNA-mediated epigenetic inheritance of metabolic disorders: impact of weight loss on the human sperm epitranscriptome

ERA-HDHL JFA2 “Nutrition & the Epigenome” (Epigenome)
Paternal RNA-mediated epigenetic inheritance of metabolic disorders: impact of weight loss on the human sperm epitranscriptome
HEROS
2019-01-01
0000-00-00
Valerie Grandjean
C3M, Inserm U1065
France

Consortium

Partner Organization Partner Country
Institut d'Investigació Biomèdica de GironaSpain
Institute of Pharmacy and BiochemistryGermany

1. Overall project description


1.1 Summary

Increasing evidence suggests that several non-communicable diseases, including obesity and its associated metabolic disorders, are inherited from parents to offspring over several generations by non-genetic mechanisms.


In this context, it has been suggested that parental environmental cues might induce epigenetic modifications in the germ line, which are transmitted to the progeny. Hence, etiological and risk factors that contribute to the insurgence of non-communicable diseases have the potential to drive the development of pathology(ies) in the progeny.


Fundamentally, the role of sperm RNA in epigenetic inheritance is not a new phenomenon and has been largely addressed in experimental models. Yet, validation in humans is quite challenging. By combining clinical trial methodology, advances in rodents and cutting-edge computing technologies in bioinformatics, we can rise to this challenge. That is the main objective of our project.The identification of the sperm epitranscriptomic signature in obese men relative to non-obese men will therefore not only provide new insights into the molecular mechanisms involved in the epigenetic inheritance of obesity in human, but also will aid the identification of new loci potentially involved in the development of metabolic pathologies. The identification of loci involved in the development of obesity is pioneering and challenging. However, if we are able to implement this ambitious project, we could give numerous insights into the nature of the mechanisms that modify the transcriptomes such a way they become able to encode and transfer complex phenotypic changes to the progeny and then counteract the development of obesity around the world. Furthermore, we might be able to identify biomarkers of environmentally-induced epigenetic perturbation. 


On the other hand, by performing microinjection of human RNA into mouse embryos, we hope to determine the role of human sperm RNA in epigenetic inheritance. This is, of course, very challenging and high risk. However, if we manage to demonstrate the role of human RNAs through these experiments, we will open new avenues in the identification of genes involved in the development of obesity and its associated diseases. 



This work will contribute to a better understanding of the molecular mechanisms involved in the non-genetic inheritance of obesity in human, and to the identification of obese-susceptibility loci whose expression can be modulated by environmental factors and consequently induce the development of the disease in successive generations.


1.2 Highlights

Since we have started the project on the 1rst of June 2020, we do not have any important and promising research so far. 



Our consortium has now developed the protocol to analyze the epitranscriptome modification from human sperm samples. 


4. Impact


4.1 List of publications

AuthorsTitleYear, Issue, PPDoiPdf

4.2 Presentation of the project

Target groupAuthorsMeans of communicationHyperlinkPdf

4.3 List of submitted patents and other outputs

Patent licencePartners involvedYearInternational eu or national patentCommentPdf

BACK

We use cookies to improve our website and your experience when using it. By continuing to navigate this site, you agree to the cookie policy. To find out more about the cookies we use and how to delete them, see our privacy policy.

  I accept cookies from this site.
EU Cookie Directive Module Information